Gobena Ameni Chimdi

Professor
Gobena Ameni
Chimdi

Professor of microbiology
Aklilu Lemma Institute of Pathobiolgy, Addis Ababa University
Biography

1)     Awarded Tore Godal Prize in 2001 for contribution to infectious diseases research

2)     Awarded the following four research grants from international funding bodies:

a)      Wellcome Trust (2005-2010): £2 million: Tuberculosis in developing countries in collaboration with six different institutions (European and African institutions). The PI of the Project was Professor Douglas Young of the Imperial College. (Gobena Ameni served as a focal researcher for the Ethiopian aspect of the Project, and PI and Coordinator for two of the seven work packages of the Project)

b)     NUFU (2007-2012): 3.5 million NK for tuberculosis research in the Afar Region in collaboration with the University of Oslo. (Gobena Ameni served as PI and Coordinator for the Ethiopian aspect of the Project)

c)       Bill & Melinda Gates Foundation, and Department for International Development (DfID) (2012-2014): $1,690,880 for investigation of vaccine against tuberculosis in collaboration with the Animal Health and Veterinary Laboratories Agency (UK) and the Armauer Hansen Research Institute. (Gobena Ameni is serving as PI and Coordinator for the Ethiopian aspect of the Project)

d)     National Institute of Health (NIH) (2013-2015): $847,000 for investigation of genomics and proteomics of tuberculosis in Ethiopia in collaboration with the J. Craig Venter Institute (JCVI, USA). (Gobena Ameni is serving as as PI and Coordinator for the Ethiopian aspect of the Project)

3)     Member of the International Working Group on Vaccine Development for Human and Animal Tuberculosis

4)     Member of the Ethiopian Veterinary Association and Ethiopian Society of Tropical and Infectious Diseases

5)     Assistant Editor of the Ethiopian Veterinary Journal

Research interests

Tuberculosis and histoplasmosis: molecular epidemiology, proteomics, treatment options and immunology/vaccinology of these diseases are the main areas of attention. The goal is to develop the tools (diagnostics, biologicals, vaccines, drugs etc.) which would help to control these diseases.